Heme Oxygenase 1 (HO-1) as an Inhibitor of Trafficking of Normal and Malignant Hematopoietic Stem Cells - Clinical and Translational Implications.

Stem Cell Reviews and Reports
Mariusz Z RatajczakMagda Kucia

Abstract

Evidence indicates that bone marrow (BM)-residing hematopoietic stem/progenitor cells (HSPCs) are released into peripheral blood (PB) after administration of pro-mobilizing drugs, which induce a state of sterile inflammation in the BM microenvironment. In the reverse process, as seen after hematopoietic transplantation, intravenously injected HSPCs home and engraft into BM niches. Here again, conditioning for transplantation by myeloablative chemo- or radiotherapy induces a state of sterile inflammation that promotes HSPC seeding to BM stem cell niches. Therefore, the trafficking of HSPCs and their progeny, including granulocytes and monocytes/macrophages, is regulated by a response to pro-inflammatory stimuli. This responsiveness to inflammatory cues is also preserved after malignant transformation of hematopoietic cells. Results from our laboratory indicate that the responsiveness of hematopoietic cells to pro-inflammatory stimuli is orchestrated by Nlrp3 inflammasome. As reported, HO-1 effectively attenuates intracellular activation of Nlrp3 inflammasome as well as the pro-inflammatory effects of several humoral mediators, including complement cascade (ComC) cleavage fragments that promote migration of hematopoietic cells. B...Continue Reading

References

Sep 1, 1997·The Journal of Clinical Investigation·K IshikawaA J Lusis
Jan 12, 1999·The Journal of Clinical Investigation·A YachieS Koizumi
May 2, 2002·Proceedings of the National Academy of Sciences of the United States of America·Johannes F M PruijtWillem E Fibbe
Mar 30, 2005·The Journal of Experimental Medicine·Ingrid G WinklerJean-Pierre Lévesque
May 14, 2005·Blood·Tsvee LapidotOrit Kollet
Jan 25, 2006·Proceedings of the National Academy of Sciences of the United States of America·Melissa van PelWillem E Fibbe
Oct 31, 2006·The American Journal of Pathology·Francesca SetaMichal Laniado-Schwartzman
Jan 22, 2008·Nature Immunology·Elaine Dzierzak, Nancy A Speck
Jun 7, 2008·Journal of Molecular and Cellular Cardiology·Heng-Huei LinLee-Young Chau
May 21, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Srivatsava NaiduStephan Immenschuh
Jul 21, 2010·Biochemical Pharmacology·Ananta PaineStephan Immenschuh
Jan 2, 2014·Oxidative Medicine and Cellular Longevity·Hun-Taeg ChungHong Pyo Kim
Dec 13, 2016·International Journal of Hematology·Joshua TayIngrid G Winkler
May 6, 2017·Antioxidants·Mariapaola NittiAnna Lisa Furfaro
Nov 13, 2017·Current Opinion in Immunology·David E Place, Thirumala-Devi Kanneganti
Oct 6, 2018·Journal of Inflammation Research·Marine Groslambert, Bénédicte F Py
May 1, 2019·The Journal of Clinical Investigation·Jingzhu ZhangDaniel C Link
May 28, 2019·Current Stem Cell Reports·Louis M Pelus, Hal E Broxmeyer
Aug 20, 2019·Archives of Biochemistry and Biophysics·George S DrummondNader G Abraham
Feb 7, 2020·F1000Research·Darja KarpovaJohn F DiPersio
Feb 23, 2020·Frontiers in Immunology·Giacomo CanesinBarbara Wegiel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.